+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Strategic Intelligence: Medical Devices M&A Deals Q3 2024 - Top Themes

  • PDF Icon

    Report

  • 28 Pages
  • October 2024
  • Region: Global
  • GlobalData
  • ID: 6029470

This report analyzes the disruptive themes that have driven M&A activity in Q3 2024 in the Medical Devices Sector

The global medical devices market witnessed deals worth $34 billion in Q3 2024, an increase of 25% compared to Q3 2023. In terms of deal volume, there were 275 M&A deals in Q3 2024, an increase of 35% compared to Q3 2023. The sector recorded 8 mega-deals (defined as any deal valued at more than $1 billion), an increase of 14% compared to Q3 2023.

Scope

  • This report provides an overview of merger and acquisition activity globally in Q3 2024 in Medical Devices Sector
  • It identifies the themes driving most notable to deals announced in Q3 2024 in the Medical Devices Sector

Reasons to Buy

  • Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
  • In this report we have listed down the most notable deals in medical devices sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.

Table of Contents

  • Executive Summary
  • Review of the Medical Devices M&A Market - Q3 2024
  • Top Medical Devices M&A Deals by Sector - Q3 2024
  • Medical Devices M&A Deals Analysis by Geography - Q3 2024
  • Top Themes Driving Medical Devices M&A Activity - Q3 2024
  • Appendix 1: Deal Selection Criteria
  • Appendix 2: Top Themes for 2024 in Medical Devices
  • Appendix 3: Thematic Research Methodology

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Affinity Equity Partners
  • Winner Medical
  • Nihon Kohden
  • Canyon Partners
  • General Atlantic
  • The Nov Sante Actions Non Cotees fund
  • Getinge
  • Edwards Lifesciences
  • The Carlyle Group
  • Johnson & Johnson
  • Fortis Healthcare
  • Resurgence PE Investments Limited
  • CooperSurgical
  • Edwards Lifesciences
  • Owens & Minor
  • Astorg Asset Management
  • Commure
  • One GE Healthcare UK
  • Quest Diagnostics
  • UFP Technologies
  • Merit Medical Systems
  • Shanghai MicroPort Endovascular MedTech Group
  • Lumus Imaging
  • Global Resources International
  • NeuroAdvanced
  • Carestream Dental
  • Moria
  • Paragonix Technologies
  • JC Medical
  • Baxter
  • V-Wave
  • Agilus Diagnostics
  • OBP Surgical
  • Endotronix
  • JenaValve Technology
  • Rotech Healthcare Holdings
  • Hamilton Thorne
  • Augmedix
  • Intelligent Ultrasound
  • LifeLabs
  • AJR Enterprises
  • EndoGastric Solutions
  • Optimum Medical Device